Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label phase 1a/2 study of Oftac eye drops for active non-infectious anterior uveitis
MOH_2022-09-08_012035Phase 2Not yet recruiting
- Sponsor
- BioNanoSim
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Oftac in anterior uveitis (AAU), sponsored by BioNanoSim. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
Oftac
03
Conditions
anterior uveitis (AAU)
Beyond the preview
Go deeper on MOH_2022-09-08_012035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2022-09-08_012035.